GelStat Corporation Announces Chicago Television Appearances

GelStat Corporation Announces Chicago Television Appearances

MINNEAPOLIS, Aug. 29 /PRNewswire-FirstCall/ -- GelStat Corporation (BULLETIN BOARD: GSAC) , a pioneer in the development and marketing of next-generation OTC pain relievers, today announced that GelStat Migraine will be featured in three television segments in Chicago.

Dr. Stephen Roberts, chairman and CEO of GelStat will be appearing today, Monday, August 29 on WGN-TV, the Chicago, Illinois WB affiliate at approximately 12:00 noon Central Time. Dr. Roberts will also be appearing on Tuesday, August 30 on WLS-TV, the ABC affiliate at approximately 6:15 a.m. Central Time and on Tuesday, August 30 on WBBN-TV, the CBS affiliate during their 11:00 a.m. Central Time news show.

Chicago is the third largest urban market in the United States. In addition, Superstation WGN programming is broadcast nationally via cable.

GelStat Migraine is available at 650 stores in the immediate Chicago area and over 20,000 locations nationally.

About GelStat Corporation

GelStat Corporation is dedicated to providing safe and effective OTC treatments for pain and inflammation. GelStat(TM) Migraine, the first product available as a result of these efforts, is a sublingually (under the tongue) administered OTC medication for acute relief from the pain and associated symptoms of migraine. Over 90 percent of the 30 million Americans with migraine use OTC headache remedies, generally aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs). Americans spend $2.6 billion each year on 600 million units of such products, though they are believed to be effective for only about 25 percent of those with moderate to severe migraine. The initial clinical trial of GelStat Migraine showed it to be effective for 83 percent of those with moderate to severe migraine.

For more information, visit http://www.gelstat.com/

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement other than a statement of historical fact should be considered a forward- looking statement. Such forward-looking statements are based on the Company's current expectations and involve known and unknown risks, uncertainties, or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation and does not intend to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect unanticipated events or developments.

Contact: Stephen C. Roberts, MD Chairman & CEO GelStat Corporation 952-881-4105 investorrelations@gelstat.com

or

Jody Janson ISD, Inc. 585-232-5440 jody@istockdaily.com www.istockdaily.com

Source: GelStat Corporation

CONTACT: Stephen C. Roberts, MD, Chairman & CEO of GelStat Corporation, +1-952-881-4105, investorrelations@gelstat.com, or Jody Janson of ISD, Inc., +1-585-232-5440, jody@istockdaily.com

Web site: http://www.gelstat.com/ http://www.istockdaily.com/

------- Profile: Ent